|
[1] V. Berger, Pros and cons of permutation tests in clinical trials, Statist. Medi. 19 (2000), 1319-1328.
[2] L. Corain and L. Salmaso, Multivariate and multistrata nonparametric tests: the nonparametric combination method, J. Modern Appl. Statist. Methods 3 (2004), 443-461.
[3] Dichiarazione Terumo Corporation del 16/6/05 (http://www.terumoitalia.it/intro.html).
[4] Directive 2007/51/EC of the European Parliament and of the Council of 25 September 2007, published in the Official Journal of the European Union of 03/10/2007.
[5] European Commission, Press Release IP/06/193 of 21/02/2006.
[6] European Parliament, Strasbourg, Community Strategy Concerning Mercury, 14/03/2006.
[7] L. Finos and L. Salmaso, Weighted methods controlling the multiplicity when the number of variables is much higher than the number of observations, J. Nonparametr. Statist. 18(2) (2006), 245-261.
[8] L. Finos, L. Salmaso and A. Solari, Conditional inference under simultaneous stochastic ordering constraints, J. Statist. Plann. Infer. 137 (2007), 2633-2641.
[9] J. Ludbrook and H. Dudley, Why permutation tests are superior to t and F tests in biomedical research, Amer. Statist. 52(2) (1998), 127-132.
[10] F. Pesarin, Multivariate Permutation Tests with Applications in Biostatistics, John Wiley & Sons, Chichester, 2001.
[11] F. Pesarin, Extending permutation conditional inference to unconditional ones, Statist. Meth. Appl. 11 (2002), 161-173.
[12] L. Salmaso and A. Solari, Multiple aspect testing for case-control designs, Metrika 62 (2005), 331-340. |